Impact of USFDA Observation For Torrent's Dahej Unit 'Limited': IndiaNivesh
  • WebDesk BTVI
  • Jul 18 2019

Torrent Pharmaceuticals shares fell more than 6 per cent intraday on July 18 after the US drug regulator classified the inspection conducted at its Dahej facility in March as Official Action Initiated (OAI). Sapna Jhawar, Senior Research Analyst - Pharmaceuticals at IndiaNivesh, discusses the impact of the USFDA move on Torrent Pharma and the outlook for the pharma industry in general.